All displayed numbers are rounded. Shares and percent changes are calculated using unrounded numbers. The detailed tables which have been made available display unrounded tabulations using IPUMS data.

Based on topline data, ZLAB said Tivdak, an antibody-drug conjugate, cut mortality risk by 45% in Chinese patients who had previously received standard systemic therapies. The Shanghai-based ...

“Positive data from this milestone study confirms isomyosamine’s historically strong safety profile and enables us to extend the duration of future clinical trials,” said Mitchell ...

Positive efficacy and safety data were observed at 3 months after a single injection of K8 in this study conducted at the University of Kentucky (NCT06164587). In the 5 patients with bilateral GA ...

Credit: MillaF / Shutterstock. Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics have reported positive topline data from Hengrui’s Phase II obesity trial, considering an 8mg dose of the ...

Data continue to demonstrate a favorable safety and efficacy profile, including improvements in IGA 0 or 1 and EASI 75 scores compared to placebo BURLINGAME, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ...

Phio Pharmaceuticals shares more than tripled after the company said it saw positive results from its Phase 1b trial for its cancer treatment PH-762. Shares were recently up more than 270% to $6. ...

The number of trials jumped to nearly 2,000 the following year and has continued climbing, reaching more than 2,300 trials last year, data shows. Cases of sexual assault and sexual exploitation ...

(NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial evaluating soquelitinib in ...

1E10 vg/eye, with 0.6 mean supplemental injections per patient through Week 32 FDA aligned with proposed single Phase 3 clinical trial being acceptable for the basis of a BLA submission for 4D-150 in ...

He goes on to discuss the significance of the regulatory approval, as well as the trial data that led the approval. Intravenous (IV): when a needle is inserted into a vein to administer fluids or ...